Jason J. Christiansen, Ph.D. - Publications

2004 University of California, Los Angeles, Los Angeles, CA 
Cell Biology, Molecular Biology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Rajasekaran SA, Christiansen JJ, Schmid I, Oshima E, Ryazantsev S, Sakamoto K, Weinstein J, Rao NP, Rajasekaran AK. Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability. Molecular Cancer Therapeutics. 7: 2142-51. PMID 18645024 DOI: 10.1158/1535-7163.MCT-08-0005  0.4
2008 Gustavson M, Dolled-Filhart M, Christiansen J, Pinard R, Rimm D. Aqua® Technology and Molecular Pathology Molecular Pathology in Drug Discovery and Development. 295-333. DOI: 10.1002/9780470475959.ch11  0.4
2007 Pelling AE, Dawson DW, Carreon DM, Christiansen JJ, Shen RR, Teitell MA, Gimzewski JK. Distinct contributions of microtubule subtypes to cell membrane shape and stability. Nanomedicine : Nanotechnology, Biology, and Medicine. 3: 43-52. PMID 17379168 DOI: 10.1016/j.nano.2006.11.006  0.4
2007 Barwe SP, Maul RS, Christiansen JJ, Anilkumar G, Cooper CR, Kohn DB, Rajasekaran AK. Preferential association of prostate cancer cells expressing prostate specific membrane antigen to bone marrow matrix. International Journal of Oncology. 30: 899-904. PMID 17332929  0.4
2006 Christiansen JJ, Weimbs T, Bander N, Rajasekaran AK. Differing effects of microtubule depolymerizing and stabilizing chemotherapeutic agents on t-SNARE-mediated apical targeting of prostate-specific membrane antigen. Molecular Cancer Therapeutics. 5: 2468-73. PMID 17041090 DOI: 10.1158/1535-7163.MCT-06-0253  0.4
2006 Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Research. 66: 8319-26. PMID 16951136 DOI: 10.1158/0008-5472.CAN-06-0410  0.48
2006 Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, Rajasekaran AK. Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature. Microvascular Research. 72: 54-61. PMID 16713605 DOI: 10.1016/j.mvr.2006.03.004  0.4
2005 Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Molecular Cancer Therapeutics. 4: 704-14. PMID 15897234 DOI: 10.1158/1535-7163.MCT-04-0171  0.4
2005 Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? American Journal of Physiology. Cell Physiology. 288: C975-81. PMID 15840561 DOI: 10.1152/ajpcell.00506.2004  0.48
2003 Christiansen JJ, Rajasekaran SA, Moy P, Butch A, Goodglick L, Gu Z, Reiter RE, Bander NH, Rajasekaran AK. Polarity of prostate specific membrane antigen, prostate stem cell antigen, and prostate specific antigen in prostate tissue and in a cultured epithelial cell line. The Prostate. 55: 9-19. PMID 12640656 DOI: 10.1002/pros.10203  0.4
Show low-probability matches.